The FDA cleared whole blood immunoassay RAMP NT-proBNP test detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure.

RAMP NT-proBNP is the Gold Standard Biomarker for Heart Failure.


Heart Disease is the Leading Cause of Death

According to CDC data, heart disease is the leading cause of death for people of most racial and ethnic groups in the United States. High blood pressure, high blood cholesterol, and smoking are key risk factors for heart disease.¹

Nearly 1 in 4 heart failure (HF) patients are readmitted within 30 days of discharge and approximately half are readmitted within 6 months.²

Heart disease is the most expensive condition to treat.³

The first step to saving lives by preventing heart disease fatalities is more comprehensive cardiac testing.


What are the advantages of RAMP NT-proBNP?

Heart failure (HF) often presents with non-specific symptoms and is frequently confused with pneumonia or COPD.

Most HF patients are treated with traditional medication that disrupts BNP levels, but NT-proBNP will not be affected. These increased BNP levels often lead to misinterpretations in the response of patients after treatment.

As the plasma levels of NT-proBNP are not affected by the medication, thus NT-proBNP is a more accurate natriuretic biomarker than BNP for HF diagnosis and prognosis.

RAMP200 Cardiac Diagnostic System

NT-proBNP is standardized to Roche Elecsys Lab Analyzer and RAMP 200 Response Bio Cardiac Diagnostic System.



  • FDA 510(k) Cleared
  • Provides rapid, accurate diagnosis and assessment of congestive heart failure in about 15 minutes
  • Aids in the risk stratification of patients suffering from heart failure
  • Provides diagnostic accuracy comparable to the Roche Elecsys proBNP
    Leave the box checked if you wish to receive occasional special offer emails, or uncheck it to decline. Don't worry, we won't spam you.